XML 115 R100.htm IDEA: XBRL DOCUMENT v3.8.0.1
Quarterly Results of Operations (unaudited) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 7 Months Ended 12 Months Ended
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Quarterly Financial Data [Abstract]                        
Total revenue $ 113,729 $ 107,912 $ 107,071 $ 106,238 $ 88,011 $ 60,210 $ 56,518 $ 49,449   $ 434,950 $ 254,188 $ 96,878
Total operating expenses 131,977 121,932 126,188 127,693 121,884 76,049 69,147 224,527   507,790 491,607 139,850
Net income (loss) (13,791) (13,129) (19,698) (23,149) (25,193) (15,775) (11,999) (173,811) $ 347,979 (69,767) (226,778) 319,814
Net income (loss) attributable to non-controlling interests (631) (541) (2,793) (5,137) (7,786) (4,567) (3,612) (51,071)   (9,102) (67,036) (12,680)
Net income (loss) attributable to Evolent Health, Inc. $ (13,160) $ (12,588) $ (16,905) $ (18,012) $ (17,407) $ (11,208) $ (8,387) $ (122,740)   $ (60,665) $ (159,742) $ 332,494
Earnings (Loss) per Common Share                        
Basic (in dollars per share) $ (0.18) $ (0.18) $ (0.28) $ (0.34) $ (0.33) $ (0.26) $ (0.20) $ (2.91)   $ (0.94) $ (3.55) $ 13.14
Diluted (in dollars per share) $ (0.18) $ (0.18) $ (0.28) $ (0.34) $ (0.33) $ (0.26) $ (0.20) $ (2.91)   $ (0.94) $ (3.55) $ 6.93